Department of Chemistry & Biochemistry, University of Oklahoma, Norman, Oklahoma 73019, United States.
J Phys Chem B. 2022 May 26;126(20):3648-3658. doi: 10.1021/acs.jpcb.2c01254. Epub 2022 May 17.
Aggregates of α-synuclein are thought to be the disease-causing agent in Parkinson's disease. Various case studies have hinted at a correlation between COVID-19 and the onset of Parkinson's disease. For this reason, we use molecular dynamics simulations to study whether amyloidogenic regions in SARS-COV-2 proteins can initiate and modulate aggregation of α-synuclein. As an example, we choose the nine-residue fragment SFYVYSRVK (SK9), located on the C-terminal of the envelope protein of SARS-COV-2. We probe how the presence of SK9 affects the conformational ensemble of α-synuclein monomers and the stability of two resolved fibril polymorphs. We find that the viral protein fragment SK9 may alter α-synuclein amyloid formation by shifting the ensemble toward aggregation-prone and preferentially rod-like fibril seeding conformations. However, SK9 has only a small effect on the stability of pre-existing or newly formed fibrils. A potential mechanism and key residues for potential virus-induced amyloid formation are described.
α- 突触核蛋白的聚集体被认为是帕金森病的致病因素。各种病例研究表明,COVID-19 与帕金森病的发病之间存在相关性。出于这个原因,我们使用分子动力学模拟来研究 SARS-COV-2 蛋白中的淀粉样蛋白区域是否可以引发和调节 α- 突触核蛋白的聚集。为此,我们选择了位于 SARS-COV-2 包膜蛋白 C 末端的九肽 SFYVYSRVK (SK9) 作为示例。我们探究了 SK9 的存在如何影响 α- 突触核蛋白单体的构象集合体以及两种解析纤维态多晶型的稳定性。我们发现,病毒蛋白片段 SK9 可能通过将集合体转向易于聚集和优先形成棒状纤维原种子构象来改变 α- 突触核蛋白的淀粉样形成。然而,SK9 对现有或新形成的纤维的稳定性只有很小的影响。描述了潜在的病毒诱导淀粉样形成的机制和关键残基。